Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
iShares Micro-Cap ETF
IWC
$1.51B
| $1.42M | ﹤0.01% |
13,145
+87
| +0.7% | +$9.47K |
|
3027
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
| $1.41M | ﹤0.01% |
47,640
+32,140
| +207% | +$922K |
|
3028
Sight Sciences
SGHT
$457M
| $1.41M | ﹤0.01% |
115,604
+12,236
| +12% | +$116K |
|
3029
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.87B
| $1.41M | ﹤0.01% |
58,591
+727
| +1% | +$16.9K |
|
3030
Nuveen ESG Large-Cap Growth ETF
NULG
$2.8B
| $1.41M | ﹤0.01% |
28,799
+22,501
| +357% | +$1.11M |
|
3031
argenx
ARGX
$53.1B
| $1.4M | ﹤0.01% |
3,707
-763
| -17% | -$285K |
|
3032
Bridgewater Bancshares
BWB
$620M
| $1.4M | ﹤0.01% |
79,099
+1,725
| +2% | +$31.6K |
|
3033
JPMorgan BetaBuilders Japan ETF
BBJP
$19.1B
| $1.4M | ﹤0.01% |
31,099
+14,897
| +92% | +$654K |
|
3034
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $1.39M | ﹤0.01% |
16,794
+11,099
| +195% | +$899K |
|
3035
Seres Therapeutics
MCRB
$45.2M
| $1.39M | ﹤0.01% |
12,445
+105
| +0.9% | +$14.1K |
|
3036
Silvercrest Asset Management
SAMG
$78.9M
| $1.39M | ﹤0.01% |
74,245
+4,918
| +7% | +$88.5K |
|
|
GTLS.PRB
3037
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
| $1.39M | ﹤0.01% |
+27,500
| New | +$1.36M |
|
3038
Inovio Pharmaceuticals
INO
$111M
| $1.39M | ﹤0.01% |
74,378
+148
| +0.2% | +$3.35K |
|
3039
MacroGenics
MGNX
$253M
| $1.39M | ﹤0.01% |
207,130
-3,849
| -2% | -$21.1K |
|
3040
Vera Therapeutics
VERA
$2.29B
| $1.39M | ﹤0.01% |
71,770
+2,272
| +3% | +$41.1K |
|
3041
Atlanticus Holdings
ATLC
$1.55B
| $1.39M | ﹤0.01% |
52,918
+16,148
| +44% | +$431K |
|
3042
Ooma
OOMA
$571M
| $1.38M | ﹤0.01% |
101,417
-7,381
| -7% | -$109K |
|
3043
Nathan's Famous
NATH
$398M
| $1.37M | ﹤0.01% |
20,422
+3,774
| +23% | +$248K |
|
|
SRNE
3044
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.36M | ﹤0.01% |
1,538,421
+223,787
| +17% | +$297K |
|
|
SLGC
3045
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.36M | ﹤0.01% |
540,806
-10,391
| -2% | -$29K |
|
3046
Centrus Energy
LEU
$3.8B
| $1.36M | ﹤0.01% |
41,718
-31,943
| -43% | -$1.22M |
|
3047
WisdomTree Europe SmallCap Dividend Fund
DFE
$170M
| $1.35M | ﹤0.01% |
+24,733
| New | +$1.28M |
|
3048
Axogen
AXGN
$2.61B
| $1.35M | ﹤0.01% |
135,441
-1,867
| -1% | -$20.7K |
|
3049
Gevo
GEVO
$410M
| $1.35M | ﹤0.01% |
710,435
-276
| -0% | -$582 |
|
3050
OmniAb
OABI
$497M
| $1.35M | ﹤0.01% |
+373,698
| New | +$1.96M |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.